Ethical implications of poor comparative effectiveness evidence: obligations in industry-research partnerships

Lancet. 2020 Mar 21;395(10228):926-928. doi: 10.1016/S0140-6736(20)30413-X.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Biomedical Research* / ethics
  • Conflict of Interest*
  • Device Approval
  • Drug Approval
  • Industry
  • Moral Obligations*